H Ben Salah1, N Fourati2, M Elloumi3, T Boudawara4, M Frikha5, J Daoud2. 1. Service de radiothérapie, CHU Habib-Bourguiba, rue Majida-Boulila, 3029 Sfax, Tunisie; Faculté de médecine, université de Sfax, Sfax, Tunisie. Electronic address: ben_salah_hanen@yahoo.fr. 2. Service de radiothérapie, CHU Habib-Bourguiba, rue Majida-Boulila, 3029 Sfax, Tunisie; Faculté de médecine, université de Sfax, Sfax, Tunisie. 3. Service d'hématologie, CHU Hédi-Chaker, Sfax, Tunisie; Faculté de médecine, université de Sfax, Sfax, Tunisie. 4. Faculté de médecine, université de Sfax, Sfax, Tunisie; Service d'anatomopathologie, CHU Habib-Bourguiba, rue Majida-Boulila, 3029 Sfax, Tunisie. 5. Faculté de médecine, université de Sfax, Sfax, Tunisie; Service de carcinologie médicale, CHU Habib-Bourguiba, rue Majida-Boulila, 3029 Sfax, Tunisie.
Abstract
PURPOSE: To study epidemiological, clinical, pathological anatomy and therapeutic results of localized primary bone lymphoma. PATIENTS AND METHODS: Between February 1993 and February 2013, four patients were treated for localized primary bone lymphoma in Sfax's hospitals (Tunisia). Treatment was decided regarding to the age of the patient, his performance status, stage of the disease, lactate dehydrogenase (LDH) and socio-economical conditions of the patient. The therapeutic evaluation was done after chemotherapy and after radiotherapy. There was a clinical, biological and radiological follow-up. RESULTS: The mean age was 59.5 years. The sex-ratio was 3. Bone localizations were clavicula, femur, humerus and mandibula. All patients had stage I large cell B lymphoma. In 3 cases, imaging showed osteolytic lesions with cortical destruction and extension to soft tissues. One patient had a fracture of the humerus. The treatment consisted in chemotherapy followed by radiotherapy. Three patients were alive with complete remission after a mean follow-up of 76 months. CONCLUSION: The treatment of primary bone lymphoma is based on a combination of chemotherapy (with or without anti-CD20) and radiotherapy. The prognosis is excellent when it is localized.
PURPOSE: To study epidemiological, clinical, pathological anatomy and therapeutic results of localized primary bone lymphoma. PATIENTS AND METHODS: Between February 1993 and February 2013, four patients were treated for localized primary bone lymphoma in Sfax's hospitals (Tunisia). Treatment was decided regarding to the age of the patient, his performance status, stage of the disease, lactate dehydrogenase (LDH) and socio-economical conditions of the patient. The therapeutic evaluation was done after chemotherapy and after radiotherapy. There was a clinical, biological and radiological follow-up. RESULTS: The mean age was 59.5 years. The sex-ratio was 3. Bone localizations were clavicula, femur, humerus and mandibula. All patients had stage I large cell B lymphoma. In 3 cases, imaging showed osteolytic lesions with cortical destruction and extension to soft tissues. One patient had a fracture of the humerus. The treatment consisted in chemotherapy followed by radiotherapy. Three patients were alive with complete remission after a mean follow-up of 76 months. CONCLUSION: The treatment of primary bone lymphoma is based on a combination of chemotherapy (with or without anti-CD20) and radiotherapy. The prognosis is excellent when it is localized.